138 related articles for article (PubMed ID: 31335415)
21. Cutaneous B-cell lymphoma with loss of CD20 immunoreactivity after rituximab therapy.
Clarke LE; Bayerl MG; Ehmann WC; Helm KF
J Cutan Pathol; 2003 Aug; 30(7):459-62. PubMed ID: 12859745
[TBL] [Abstract][Full Text] [Related]
22. A rare pediatric case of a thymic cytotoxic and lymphoblastic T/NK cell lymphoma.
Gaiser T; Haedicke W; Becker MR
Int J Clin Exp Pathol; 2010 Mar; 3(4):437-42. PubMed ID: 20490334
[TBL] [Abstract][Full Text] [Related]
23. Precursor B-Lymphoblastic lymphoma presenting as a solitary bone tumor and mimicking Ewing's sarcoma: a report of four cases and review of the literature.
Ozdemirli M; Fanburg-Smith JC; Hartmann DP; Shad AT; Lage JM; Magrath IT; Azumi N; Harris NL; Cossman J; Jaffe ES
Am J Surg Pathol; 1998 Jul; 22(7):795-804. PubMed ID: 9669342
[TBL] [Abstract][Full Text] [Related]
24. TDT (-), KIT (+), CD34 (+), CD99 (+) precursor T lymphoblastic leukemia/lymphoma.
Terada T
Int J Clin Exp Pathol; 2012; 5(2):167-70. PubMed ID: 22400079
[TBL] [Abstract][Full Text] [Related]
25. Cutaneous B-cell lymphoblastic lymphoma in children: a rare diagnosis.
Boccara O; Laloum-Grynberg E; Jeudy G; Aubriot-Lorton MH; Vabres P; de Prost Y; Pacquement H; Brousse N; Fraitag S; Bodemer C
J Am Acad Dermatol; 2012 Jan; 66(1):51-7. PubMed ID: 21745698
[TBL] [Abstract][Full Text] [Related]
26. CD20-negative relapse of cutaneous B-cell lymphoma after anti-CD20 monoclonal antibody therapy.
Massengale WT; McBurney E; Gurtler J
J Am Acad Dermatol; 2002 Mar; 46(3):441-3. PubMed ID: 11862185
[TBL] [Abstract][Full Text] [Related]
27. Precursor B-cell lymphoblastic lymphoma. A study of nine cases lacking blood and bone marrow involvement and review of the literature.
Maitra A; McKenna RW; Weinberg AG; Schneider NR; Kroft SH
Am J Clin Pathol; 2001 Jun; 115(6):868-75. PubMed ID: 11392884
[TBL] [Abstract][Full Text] [Related]
28. Cutaneous precursor B-cell lymphoblastic lymphoma in 2 adult patients: clinicopathologic and molecular cytogenetic studies with a review of the literature.
Shafer D; Wu H; Al-Saleem T; Reddy K; Borghaei H; Lessin S; Smith M
Arch Dermatol; 2008 Sep; 144(9):1155-62. PubMed ID: 18794461
[TBL] [Abstract][Full Text] [Related]
29. Lineage determination of CD20- B-Cell neoplasms: an immunohistochemical study.
Chu PG; Loera S; Huang Q; Weiss LM
Am J Clin Pathol; 2006 Oct; 126(4):534-44. PubMed ID: 16938666
[TBL] [Abstract][Full Text] [Related]
30. Terminal deoxynucleotidyl transferase negative T-cell lymphoblastic lymphoma in aleukemic patient.
Brčić I; Labar B; Perić-Balja M; Bašić-Kinda S; Nola M
Int J Hematol; 2008 Sep; 88(2):189-191. PubMed ID: 18512118
[TBL] [Abstract][Full Text] [Related]
31. Primary cutaneous lymphoblastic lymphoma presenting in an 8-week old infant.
Trupiano JK; Bringelsen K; Hsi ED
J Cutan Pathol; 2002 Feb; 29(2):107-12. PubMed ID: 12150131
[TBL] [Abstract][Full Text] [Related]
32. Precursor B-cell lymphoblastic lymphoma involving the skin.
Kim JY; Kim YC; Lee ES
J Cutan Pathol; 2006 Sep; 33(9):649-53. PubMed ID: 16965342
[TBL] [Abstract][Full Text] [Related]
33. Very late central nervous system relapse in a patient with B cell lymphoblastic lymphoma.
Nagasaki A; Miyagi T; Nakazato T; Taira N; Ohshima K; Kikuchi M; Takasu N; Masauda M
Acta Haematol; 2004; 112(4):212-6. PubMed ID: 15564734
[TBL] [Abstract][Full Text] [Related]
34. Cutaneous double-hit B-cell lymphoma: an aggressive form of B-cell lymphoma with a propensity for cutaneous dissemination.
Magro CM; Wang X; Subramaniyam S; Darras N; Mathew S
Am J Dermatopathol; 2014 Apr; 36(4):303-10. PubMed ID: 23907319
[TBL] [Abstract][Full Text] [Related]
35. Angiotropic lymphoma: an immunophenotypically and clinically heterogeneous lymphoma.
Yegappan S; Coupland R; Arber DA; Wang N; Miocinovic R; Tubbs RR; Hsi ED
Mod Pathol; 2001 Nov; 14(11):1147-56. PubMed ID: 11706077
[TBL] [Abstract][Full Text] [Related]
36. Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Willemze R; Hodak E; Zinzani PL; Specht L; Ladetto M;
Ann Oncol; 2018 Oct; 29(Suppl 4):iv30-iv40. PubMed ID: 29878045
[No Abstract] [Full Text] [Related]
37. Primary cutaneous follicular lymphoma: an assessment of clinical, histopathologic, immunophenotypic, and molecular features.
Mirza I; Macpherson N; Paproski S; Gascoyne RD; Yang B; Finn WG; Hsi ED
J Clin Oncol; 2002 Feb; 20(3):647-55. PubMed ID: 11821444
[TBL] [Abstract][Full Text] [Related]
38. Human Herpesvirus Type 8-associated Large B-cell Lymphoma: A Nonserous Extracavitary Variant of Primary Effusion Lymphoma in an HIV-infected Man: A Case Report and Review of the Literature.
Foster WR; Bischin A; Dorer R; Aboulafia DM
Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):311-21. PubMed ID: 27234438
[TBL] [Abstract][Full Text] [Related]
39. [Febrile cellulitis surrounding a scar revealing a large immunoblastic B-cell lymphoma].
Charavin-Cocuzza M; Templier I; Simon A; Salameire D; Cuchet E; Reymond JL; Beani JC; Leccia MT
Ann Dermatol Venereol; 2008 Dec; 135(12):848-51. PubMed ID: 19084696
[TBL] [Abstract][Full Text] [Related]
40. Development-associated immunophenotypes reveal the heterogeneous and individualized early responses of adult B-acute lymphoblastic leukemia.
Li HF; Meng WT; Jia YQ; Jiang NG; Zeng TT; Jin YM; Huang QR; Li X; Xu H; Mo XM
Medicine (Baltimore); 2016 Aug; 95(34):e4128. PubMed ID: 27559941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
